Pulmonary Disease Doctors in Concord, CA Accepting Medicare

4 Pulmonary Disease doctors found. Showing 1 - 4

Hiromi Takekuma, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2299 Bacon St, Suite 2, Concord, CA 94520 Phone: 925-676-2942    Fax: 925-676-7108

David Safianoff, M.D. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2485 High School Ave, Suite 301, Concord, CA 94520 Phone: 925-676-2942    Fax: 925-676-7108

John Hadley, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2299 Bacon St, Suite 2, Concord, CA 94520 Phone: 925-676-2942    Fax: 925-676-7108

Richard Kops, M.D. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2299 Bacon St Ste 2, Concord, CA 94520 Phone: 925-676-2942    Fax: 925-676-7108

News Archive

Study to determine the outcomes and complications of ERCP in a community practice to appear in GIE journal

A new study from researchers in Minnesota found that endoscopic retrograde cholangiopancreatography (ERCP) performed in a community hospital setting results in complication rates that compare favorably with those of academic centers while achieving technical success at or above the performance levels recommended by the American Society for Gastrointestinal Endoscopy (ASGE)/American College of Gastroenterology (ACG) Task Force.

AAD honors board-certified dermatologists for treatment of a patient with aquagenic keratoderma

The American Academy of Dermatology has honored board-certified dermatologists Jean-Pierre Galliani, MD, FAAD, and Naomi Johansen, MD, FAAD, as Patient Care Heroes for their diagnosis and treatment of a patient with aquagenic keratoderma, a rare condition that causes extreme, painful wrinkles of the palms after exposure to water.

Children could be saved from neuroblastoma using antibody therapy

Combination of T cell, antibody to neuroblastoma cells and molecule that spurs T cell growth is designed to treat low initial tumor levels or small cancer cell populations that survive initial treatment, according to St. Jude.

Viewpoints: Target has the right idea for part-timers; health law 'beyond rescue;' fighting back to secure the right to abortion

The big noise on the health insurance front today was sounded by Target, which announced via a corporate blog that it's ending health insurance for its part-time workers. Instead of signing up for a company plan, they're encouraged to use the health care exchanges set up through the Affordable Care Act. ...

Researchers investigate FDA influence for improving pivotal drug studies

An examination of the potential interaction between pharmaceutical companies and the U.S. Food and Drug Administration (FDA) to discuss future studies finds that one-quarter of recent new drug approvals occurred without any meeting, and when such meetings occurred, pharmaceutical companies did not comply with one-quarter of the recommendations made by the FDA regarding study design or primary outcome, according to a study in the November 26 issue of JAMA.

Read more Medical News

› Verified 1 days ago